Opthea Limited Logo

Opthea Limited

OPT

(1.2)
Stock Price

3,34 USD

-117.02% ROA

398.06% ROE

-1.78x PER

Market Cap.

711.539.243,00 USD

-264.65% DER

0% Yield

-138376.57% NPM

Opthea Limited Stock Analysis

Opthea Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Opthea Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-14.5x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-3%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

Negative ROE (-675.16%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-144.48%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Opthea Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Opthea Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Opthea Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Opthea Limited Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 180.344 100%
1998 118.956 -51.61%
1999 1.954.258.284 99.99%
2000 0 0%
2001 0 0%
2002 5.403 100%
2003 0 0%
2004 8.610 100%
2005 10.104 14.8%
2006 0 0%
2007 16.211 100%
2008 13.777 -17.67%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 582.414 100%
2014 746.029 21.93%
2015 445.175 -67.58%
2016 251.530 -76.99%
2017 57.535 -337.18%
2018 107.378 46.42%
2019 112.497 4.55%
2020 59.061 -90.48%
2021 68.613 13.92%
2022 90.683 24.34%
2023 108.406 16.35%
2024 255.336 57.54%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Opthea Limited Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 5.881 100%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 370.529 100%
1999 238.284 -55.5%
2000 111.725 -113.28%
2001 284.264 60.7%
2002 81.677 -248.03%
2003 72.307 -12.96%
2004 246.131 70.62%
2005 404.198 39.11%
2006 886.703 54.42%
2007 2.266.547 60.88%
2008 3.140.711 27.83%
2009 2.892.663 -8.58%
2010 3.076.533 5.98%
2011 7.510.054 59.03%
2012 3.723.029 -101.72%
2013 2.899.035 -28.42%
2014 5.135.128 43.55%
2015 5.549.133 7.46%
2016 2.606.087 -112.93%
2017 3.648.814 28.58%
2018 19.286.952 81.08%
2019 22.418.540 13.97%
2020 12.035.925 -86.26%
2021 25.891.851 53.51%
2022 78.654.217 67.08%
2023 122.128.314 35.6%
2024 366.742.120 66.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Opthea Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 45.868 100%
1992 32.281 -42.09%
1993 50.172 35.66%
1994 82.460 39.16%
1995 94.150 12.42%
1996 161.572 41.73%
1997 189.190 14.6%
1998 0 0%
1999 220.911 100%
2000 192.560 -14.72%
2001 966.395 80.07%
2002 655.648 -47.4%
2003 898.056 26.99%
2004 944.045 4.87%
2005 1.248.444 24.38%
2006 1.505.280 17.06%
2007 2.877.238 47.68%
2008 3.301.541 12.85%
2009 3.011.469 -9.63%
2010 3.849.684 21.77%
2011 4.668.253 17.53%
2012 3.626.576 -28.72%
2013 2.874.012 -26.19%
2014 3.061.946 6.14%
2015 2.522.453 -21.39%
2016 2.943.841 14.31%
2017 3.538.342 16.8%
2018 3.380.062 -4.68%
2019 5.087.508 33.56%
2020 6.609.639 23.03%
2021 11.878.179 44.35%
2022 16.304.959 27.15%
2023 19.270.494 15.39%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Opthea Limited EBITDA
Year EBITDA Growth
1989 -388.915
1990 -495.247 21.47%
1991 -125.257 -295.39%
1992 -53.989 -132%
1993 -233.394 76.87%
1994 -57.457 -306.21%
1995 -372.049 84.56%
1996 -763.119 51.25%
1997 180.344 523.15%
1998 118.956 -51.61%
1999 1.954.258.284 99.99%
2000 -320.699 609474.61%
2001 -414.982 22.72%
2002 -1.815.667 77.14%
2003 -1.997.193 9.09%
2004 -1.255.300 -59.1%
2005 13.354.162 109.4%
2006 -2.883.984 563.05%
2007 -32.100.303 91.02%
2008 -12.122.147 -164.81%
2009 -6.055.282 -100.19%
2010 -8.572.400 29.36%
2011 -11.974.944 28.41%
2012 -9.023.680 -32.71%
2013 -6.677.070 -35.14%
2014 -6.401.822 -4.3%
2015 -6.747.606 5.12%
2016 -5.860.960 -15.13%
2017 -7.442.920 21.25%
2018 -23.152.590 67.85%
2019 -26.369.410 12.2%
2020 -16.961.510 -55.47%
2021 -39.163.279 56.69%
2022 -96.224.113 59.3%
2023 -146.697.071 34.41%
2024 -391.995.440 62.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Opthea Limited Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 180.344 100%
1998 118.956 -51.61%
1999 1.954.258.284 99.99%
2000 -16.412 11907596.25%
2001 0 0%
2002 5.403 100%
2003 0 0%
2004 8.610 100%
2005 10.104 14.8%
2006 0 0%
2007 16.211 100%
2008 13.777 -17.67%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 18.940 100%
2014 212.249 91.08%
2015 179.855 -18.01%
2016 229.124 21.5%
2017 37.464 -511.58%
2018 85.175 56.02%
2019 88.831 4.12%
2020 -458.203 119.39%
2021 -503.369 8.97%
2022 -141.786 -255.02%
2023 -142.066 0.2%
2024 47.916 396.49%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Opthea Limited Net Profit
Year Net Profit Growth
1989 -312.049
1990 -388.810 19.74%
1991 -106.439 -265.29%
1992 -45.084 -136.09%
1993 -228.914 80.31%
1994 -32.985 -594.02%
1995 -336.616 90.2%
1996 -676.740 50.26%
1997 -790.051 14.34%
1998 -759.047 -4.08%
1999 1.052.199.108 100.07%
2000 438.381 -239919.32%
2001 -411.834 206.45%
2002 -1.825.520 77.44%
2003 -1.604.240 -13.79%
2004 2.854.752 156.2%
2005 12.570.342 77.29%
2006 -3.544.913 454.6%
2007 9.502.444 137.31%
2008 -1.054.298 1001.31%
2009 -6.398.110 83.52%
2010 -4.976.679 -28.56%
2011 -11.733.973 57.59%
2012 -5.008.580 -134.28%
2013 -4.010.963 -24.87%
2014 -3.768.700 -6.43%
2015 -4.088.258 7.82%
2016 -4.735.411 13.67%
2017 -4.670.385 -1.39%
2018 -13.096.528 64.34%
2019 -14.953.894 12.42%
2020 -11.080.783 -34.95%
2021 -45.344.496 75.56%
2022 -92.817.371 51.15%
2023 -142.521.085 34.87%
2024 -495.968.680 71.26%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Opthea Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 260 100%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 1 0%
2005 2 100%
2006 -1 0%
2007 2 100%
2008 0 0%
2009 -1 100%
2010 -1 0%
2011 -2 100%
2012 -1 0%
2013 -1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 -1 100%
2022 -2 0%
2023 -2 50%
2024 -6 60%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Opthea Limited Free Cashflow
Year Free Cashflow Growth
1989 0
1990 -1 0%
1991 -151.060 100%
1992 -198.942 24.07%
1993 -235.388 15.48%
1994 -347.322 32.23%
1995 -481.998 27.94%
1996 -964.995 50.05%
1997 -1.339.148 27.94%
1998 -44.534 -2907.09%
1999 -8.285.652 99.46%
2000 -8.793 -94140.81%
2001 -530.053 98.34%
2002 -594.605 10.86%
2003 -10.261 -5695.36%
2004 -1.205.436 99.15%
2005 -1.244.408 3.13%
2006 -2.140.687 41.87%
2007 27.895.759 107.67%
2008 -1.755.911 1688.68%
2009 -5.277.192 66.73%
2010 -6.373.562 17.2%
2011 -10.158.027 37.26%
2012 -7.298.047 -39.19%
2013 -5.190.894 -40.59%
2014 -4.285.430 -21.13%
2015 -5.026.656 14.75%
2016 -2.687.345 -87.05%
2017 -4.561.501 41.09%
2018 -15.475.075 70.52%
2019 -11.921.997 -29.8%
2020 -5.694.593 -109.36%
2021 -45.558.869 87.5%
2022 -71.351.862 36.15%
2023 -120.630.333 40.85%
2024 -91.057.477 -32.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Opthea Limited Operating Cashflow
Year Operating Cashflow Growth
1989 0
1990 -1 0%
1991 -151.060 100%
1992 -198.942 24.07%
1993 -235.388 15.48%
1994 -341.470 31.07%
1995 -478.961 28.71%
1996 -958.781 50.04%
1997 -1.305.443 26.56%
1998 0 0%
1999 -1 100%
2000 0 0%
2001 -516.674 100%
2002 -587.613 12.07%
2003 0 0%
2004 -1.202.551 100%
2005 -1.239.190 2.96%
2006 -2.131.656 41.87%
2007 27.943.275 107.63%
2008 -1.726.278 1718.7%
2009 -5.267.637 67.23%
2010 -6.356.981 17.14%
2011 -10.070.150 36.87%
2012 -7.258.187 -38.74%
2013 -5.188.373 -39.89%
2014 -4.174.307 -24.29%
2015 -5.026.656 16.96%
2016 -2.678.813 -87.64%
2017 -4.559.180 41.24%
2018 -15.448.408 70.49%
2019 -11.913.151 -29.68%
2020 -5.689.620 -109.38%
2021 -45.546.167 87.51%
2022 -71.334.952 36.15%
2023 -120.608.379 40.85%
2024 -91.028.295 -32.5%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Opthea Limited Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 5.852 100%
1995 3.037 -92.69%
1996 6.214 51.13%
1997 33.705 81.56%
1998 44.533 24.31%
1999 8.285.651 99.46%
2000 8.793 -94140.79%
2001 13.378 34.28%
2002 6.992 -91.36%
2003 10.261 31.86%
2004 2.885 -255.76%
2005 5.218 44.73%
2006 9.030 42.21%
2007 47.515 81%
2008 29.633 -60.35%
2009 9.555 -210.15%
2010 16.582 42.38%
2011 87.877 81.13%
2012 39.860 -120.46%
2013 2.521 -1481.12%
2014 111.123 97.73%
2015 0 0%
2016 8.532 100%
2017 2.321 -267.76%
2018 26.667 91.3%
2019 8.846 -201.46%
2020 4.973 -77.88%
2021 12.702 60.85%
2022 16.910 24.88%
2023 21.954 22.98%
2024 29.182 24.77%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Opthea Limited Equity
Year Equity Growth
1989 1.858.529
1990 1.188.341 -56.4%
1991 1.009.697 -17.69%
1992 1.227.834 17.77%
1993 1.090.813 -12.56%
1994 1.528.459 28.63%
1995 1.478.579 -3.37%
1996 3.025.754 51.13%
1997 3.991.800 24.2%
1998 2.671.977 -49.39%
1999 4.758.538 43.85%
2000 9.002.226 47.14%
2001 12.440.017 27.63%
2002 13.140.944 5.33%
2003 16.643.743 21.05%
2004 20.513.258 18.86%
2005 21.679.687 5.38%
2006 31.048.923 30.18%
2007 43.823.741 29.15%
2008 47.219.451 7.19%
2009 25.016.044 -88.76%
2010 22.791.148 -9.76%
2011 24.946.481 8.64%
2012 20.912.189 -19.29%
2013 12.112.660 -72.65%
2014 9.866.171 -22.77%
2015 16.660.488 40.78%
2016 11.152.733 -49.38%
2017 41.798.060 73.32%
2018 28.203.711 -48.2%
2019 15.275.584 -84.63%
2020 30.881.073 50.53%
2021 135.285.768 77.17%
2022 47.977.144 -181.98%
2023 -5.853.178 919.68%
2024 -75.810.077 92.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Opthea Limited Assets
Year Assets Growth
1989 1.857.955
1990 1.208.377 -53.76%
1991 1.013.813 -19.19%
1992 1.243.419 18.47%
1993 1.097.981 -13.25%
1994 1.547.611 29.05%
1995 1.527.173 -1.34%
1996 3.100.948 50.75%
1997 4.117.223 24.68%
1998 2.771.925 -48.53%
1999 4.853.036 42.88%
2000 9.133.117 46.86%
2001 12.525.270 27.08%
2002 13.258.852 5.53%
2003 16.859.819 21.36%
2004 20.733.044 18.68%
2005 24.927.728 16.83%
2006 32.318.301 22.87%
2007 48.059.765 32.75%
2008 49.465.436 2.84%
2009 26.632.851 -85.73%
2010 24.831.262 -7.26%
2011 28.007.870 11.34%
2012 23.405.620 -19.66%
2013 13.844.505 -69.06%
2014 11.732.288 -18%
2015 18.463.893 36.46%
2016 12.697.365 -45.42%
2017 43.372.586 70.72%
2018 34.043.144 -27.4%
2019 18.486.315 -84.15%
2020 34.254.246 46.03%
2021 138.409.168 75.25%
2022 60.046.819 -130.5%
2023 98.641.319 39.13%
2024 188.791.215 47.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Opthea Limited Liabilities
Year Liabilities Growth
1989 26.386
1990 20.035 -31.7%
1991 22.346 10.34%
1992 28.941 22.79%
1993 14.334 -101.9%
1994 23.407 38.76%
1995 49.099 52.33%
1996 75.192 34.7%
1997 125.423 40.05%
1998 99.948 -25.49%
1999 94.497 -5.77%
2000 130.890 27.8%
2001 85.251 -53.53%
2002 117.908 27.7%
2003 216.076 45.43%
2004 219.785 1.69%
2005 3.248.039 93.23%
2006 1.269.377 -155.88%
2007 4.236.022 70.03%
2008 2.245.983 -88.6%
2009 1.616.805 -38.91%
2010 2.040.112 20.75%
2011 3.061.388 33.36%
2012 2.493.429 -22.78%
2013 1.731.843 -43.98%
2014 1.866.116 7.2%
2015 1.803.404 -3.48%
2016 1.544.632 -16.75%
2017 1.574.525 1.9%
2018 5.839.433 73.04%
2019 3.210.730 -81.87%
2020 3.373.172 4.82%
2021 3.123.400 -8%
2022 12.069.675 74.12%
2023 104.494.497 88.45%
2024 264.601.292 60.51%

Opthea Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-2.6
Price to Earning Ratio
-1.78x
Price To Sales Ratio
5687.4x
POCF Ratio
-2.44
PFCF Ratio
-4.42
Price to Book Ratio
-5.17
EV to Sales
5912.47
EV Over EBITDA
-3.84
EV to Operating CashFlow
-4.6
EV to FreeCashFlow
-4.6
Earnings Yield
-0.56
FreeCashFlow Yield
-0.23
Market Cap
0,71 Bil.
Enterprise Value
0,74 Bil.
Graham Number
7.24
Graham NetNet
-0.98

Income Statement Metrics

Net Income per Share
-2.6
Income Quality
0.73
ROE
3.6
Return On Assets
-1.29
Return On Capital Employed
-2
Net Income per EBT
0.95
EBT Per Ebit
1.03
Ebit per Revenue
-1413.43
Effective Tax Rate
0.05

Margins

Sales, General, & Administrative to Revenue
72.33
Research & Developement to Revenue
1414.31
Stock Based Compensation to Revenue
13.49
Gross Profit Margin
-0.17
Operating Profit Margin
-1413.43
Pretax Profit Margin
-1460.06
Net Profit Margin
-1383.77

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.9
Free CashFlow per Share
-1.9
Capex to Operating CashFlow
-0
Capex to Revenue
0.27
Capex to Depreciation
0.32
Return on Invested Capital
-1.48
Return on Tangible Assets
-1.17
Days Sales Outstanding
34497.56
Days Payables Outstanding
134353.06
Days of Inventory on Hand
0
Receivables Turnover
0.01
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
2,03
Book Value per Share
-0,89
Tangible Book Value per Share
-0.89
Shareholders Equity per Share
-0.89
Interest Debt per Share
2.72
Debt to Equity
-2.65
Debt to Assets
1.06
Net Debt to EBITDA
-0.15
Current Ratio
2.94
Tangible Asset Value
-0,08 Bil.
Net Current Asset Value
-0,08 Bil.
Invested Capital
124268857
Working Capital
0,12 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,03 Bil.
Average Inventory
0
Debt to Market Cap
0.28

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Opthea Limited Dividends
Year Dividends Growth

Opthea Limited Profile

About Opthea Limited

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

CEO
Dr. Frederic Guerard M.S., Ph
Employee
33
Address
650 Chapel Street
South Yarra, 3141

Opthea Limited Executives & BODs

Opthea Limited Executives & BODs
# Name Age
1 Mr. Anand Sundaram
Vice President Marketing
70
2 Mr. Thomas Charles Reilly
Chief Financial Officer
70
3 Dr. Arshad M. Khanani M.A., M.D.
Chief Medical Advisor & Chairman of Medical Advisory Board
70
4 Ms. Karen Adams CPA
Vice President of Finance & Company Secretary
70
5 Dr. Frederic Guerard M.S., Pharm.D.
Chief Executive Officer
70
6 Dr. Fang Li Ph.D.
Senior Vice President of Regulatory Affairs
70
7 Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.
Founder & Chief Innovation Officer
70
8 Mr. Kevin Bitter
Vice President of Strategy & Corporate Development
70
9 Dr. Julie Clark M.D., M.S.
Senior Vice President of Clinical Development
70
10 Ms. Jen Watts
Vice President Global Clinical Operations
70

Opthea Limited Competitors